Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus

British Journal of Pharmacology

Volumn 172, Issue 14, 2015, Pages 3638-3649

  Pačesová, Dominika ^a   Volfová, Barbora ^a   Červená, Kateřina ^a   Hejnová, Lucie ^a   Novotný, Jiří ^a   Bendová, Zdeňka ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MU OPIATE RECEPTOR; PER1 PROTEIN; PER2 PROTEIN; PROTEIN C FOS; CIRCADIAN RHYTHM SIGNALING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE; PER1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN TISSUE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE INDUCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGHT DARK CYCLE; MALE; NONHUMAN; PER1 GENE; PERIOD2 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; ANIMAL; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; WISTAR RAT;

ANIMALS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; PERIOD CIRCADIAN PROTEINS; PHOSPHORYLATION; RATS; RATS, WISTAR; SUPRACHIASMATIC NUCLEUS;

EID: 84933040356     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13152     Document Type: Article

References (66)

1. Akiyama M, Kouzu Y, Takahashi S, Wakamatsu H, Moriya T, Maetani M, et al. (1999). Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms. J Neurosci 19: 1115-1121.
2. Albrecht U, Sun ZS, Eichele G, Lee CC, (1997). A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 9: 1055-1064.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol 170: 1652-1675.
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
6. Antle MC, Kriegsfeld LJ, Silver R, (2005a). Signaling within the master clock of the brain: localized activation of mitogen-activated protein kinase by gastrin-releasing peptide. J Neurosci 25: 2447-2454.
7. Antle MC, LeSauter J, Silver R, (2005b). Neurogenesis and ontogeny of specific cell phenotypes within the hamster suprachiasmatic nucleus. Brain Res Dev Brain Res 157: 8-18.
8. Antle MC, Tse F, Koke SJ, Sterniczuk R, Hagel K, (2008). Non-photic phase shifting of the circadian clock: role of the extracellular signal-responsive kinases I/II/mitogen-activated protein kinase pathway. Eur J Neurosci 28: 2511-2518.
9. Berhow MT, Hiroi N, Nestler EJ, (1996). Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16: 4707-4715.
10. Boom M, Grefkens J, van Dorp E, Olofsen E, Lourenssen G, Aarts L, et al. (2010). Opioid chronopharmacology: influence of timing of infusion on fentanyl's analgesic efficacy in healthy human volunteers. J Pain Res 21: 183-190.
11. Borgkvist A, Usiello A, Greengard P, Fisone G, (2007). Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology 32: 1995-2003.
12. Buhr ED, Takahashi JS, (2013). Molecular components of the mammalian circadian clock. Handb Exp Pharmacol 217: 3-27.
13. Byku M, Gannon RL, (2000a). SNC 80, a delta-opioid agonist, elicits phase advances in hamster circadian activity rhythms. Neuroreport 11: 1449-1452.
14. Byku M, Gannon RL, (2000b). Opioid induced non-photic phase shifts of hamster circadian activity rhythms. Brain Res 873: 189-196.
15. Byku M, Legutko R, Gannon RL, (2000). Distribution of delta opioid receptor immunoreactivity in the hamster suprachiasmatic nucleus and intergeniculate leaflet. Brain Res 857: 1-7.
16. Chen JC, Smith ER, Cahill M, Cohen R, Fishman JB, (1993). The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci 52: 389-396.
17. Cutler DJ, Mundey MK, Mason R, (1999). Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro. Brain Res Bull 50: 119-125.
18. Dehpour AR, Farsam H, Azizabadi-Farahani M, (1994). The effect of lithium on morphine-induced analgesia in mice. Gen Pharmacol 25: 1635-1641.
19. Desjardins GC, Brawer JR, Beaudet A, (1990). Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat. Brain Res 536: 114-123.
20. Dimsdale JE, Norman D, DeJardin D, Wallace MS, (2007). The effect of opioids on sleep architecture. J Clin Sleep Med 3: 33-36.
21. Ding YQ, Kaneko T, Nomura S, Mizuno N, (1996). Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol 367: 375-402.
22. Dziema H, Oatis B, Butcher GQ, Yates R, Hoyt KR, Obrietan K, (2003). The ERK/MAP kinase pathway couples light to immediate-early gene expression in the suprachiasmatic nucleus. Eur J Neurosci 17: 1617-1627.
23. Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D Jr, et al. (2003). Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 23: 8360-8369.
24. Fukuhara C, Brewer JM, Dirden JC, Bittman EL, Tosini G, Harrington ME, (2001). Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus. Neurosci Lett 314: 119-122.
25. Guillaumond F, Becquet D, Blanchard MP, Attia J, Moreno M, Bosler O, et al. (2007). Nocturnal expression of phosphorylated-ERK1/2 in gastrin-releasing peptide neurons of the rat suprachiasmatic nucleus. J Neurochem 101: 1224-1235.
26. Harada Y, Sakai M, Kurabayashi N, Hirota T, Fukada Y, (2005). Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta. J Biol Chem 280: 31714-31721.
27. Horikawa K, Yokota S, Fuji K, Akiyama M, Moriya T, Okamura H, et al. (2000). Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci 20: 5867-5873.
28. Iitaka C, Miyazaki K, Akaike T, Ishida N, (2005). A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 280: 29397-29402.
29. Kalsbeek A, Fliers E, Hofman MA, Swaab DF, Buijs RM, (2010). Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol 22: 362-372.
30. Karatsoreos IN, Yan L, LeSauter J, Silver R, (2004). Phenotype matters: identification of light-responsive cells in the mouse suprachiasmatic nucleus. J Neurosci 24: 68-75.
31. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
32. Ko CH, Takahashi JS, (2006). Molecular components of the mammalian circadian clock. Hum Mol Genet 15: R271-R277.
33. Ko HW, Kim EY, Chiu J, Vanselow JT, Kramer A, Edery I, (2010). A hierarchical phosphorylation cascade that regulates the timing of PERIOD nuclear entry reveals novel roles for proline-directed kinases and GSK-3beta/SGG in circadian clocks. J Neurosci 30: 12664-12675.
34. Lambert CM, Machida KK, Smale L, Nunez AA, Weaver DR, (2005). Analysis of the prokineticin 2 system in a diurnal rodent, the unstriped Nile grass rat (Arvicanthis niloticus). J Biol Rhythms 20: 206-218.
35. Lavoie J, Hébert M, Beaulieu JM, (2013). Glycogen synthase kinase-3β haploinsufficiency lengthens the circadian locomotor activity period in mice. Behav Brain Res 253: 262-265.
36. Li LY, Chang KJ, (1996). The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol Pharmacol 50: 599-602.
37. Liu J, Nickolenko J, Sharp FR, (1994). Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 91: 8537-8541.
38. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, et al. (1994). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438.
39. Marchant EG, Mistlberger RE, (1995). Morphine phase-shifts circadian rhythms in mice: role of behavioural activation. Neuroreport 7: 209-712.
40. Maywood ES, Mrosovsky N, Field MD, Hastings MH, (1999). Rapid down-regulation of mammalian period genes during behavioral resetting of the circadian clock. Proc Natl Acad Sci U S A 96: 15211-15216.
41. McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK, (2012). A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS ONE 7: e32091.
42. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
43. Meijer JH, Ruijs AC, Albus H, van de Geest B, Duindam H, Zwinderman AH, et al. (2000). Fentanyl, a upsilon-opioid receptor agonist, phase shifts the hamster circadian pacemaker. Brain Res 868: 135-140.
44. Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, Borea PA, (2013). Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCε-Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol 86: 487-496.
45. Morin LP, (2007). SCN organization reconsidered. J Biol Rhythms 22: 3-13.
46. Naber D, Cohen RM, Pickar D, Kalin NH, Davis G, Pert CB, et al. (1981). Episodic secretion of opioid activity in human plasma and monkey CSF: evidence for a diurnal rhythm. Life Sci 28: 931-935.
47. Nakaya M, Sanada K, Fukada Y, (2003). Spatial and temporal regulation of mitogen-activated protein kinase phosphorylation in the mouse suprachiasmatic nucleus. Biochem Biophys Res Commun 305: 494-501.
48. Obrietan K, Impey S, Storm DR, (1998). Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1: 693-700.
49. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ, (1995). Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15: 1285-1297.
50. Osland TM, Fernø J, Håvik B, Heuch I, Ruoff P, Lærum OD, et al. (2011). Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J Psychopharmacol 25: 924-933.
51. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
52. Raffa RB, Martinez RP, Renzi MJ, Codd EE, (1995). LiCl uncouples signal transduction in morphine-induced supraspinal antinociception in mice. Gen Pharmacol 26: 317-320.
53. Raymond RC, Warren M, Morris RW, Leikin JB, (1992). Periodicity of presentations of drugs of abuse and overdose in an emergency department. J Toxicol Clin Toxicol 30: 467-478.
54. Reischl S, Kramer A, (2011). Kinases and phosphatases in the mammalian circadian clock. FEBS Lett 585: 1393-1399.
55. Sahar S, Zocchi L, Kinoshita C, Borrelli E, Sassone-Corsi P, (2010). Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS ONE 5: e8561.
56. Sanada K, Okano T, Fukada Y, (2002). Mitogen-activated protein kinase phosphorylates and negatively regulates basic helix-loop-helix-PAS transcription factor BMAL1. J Biol Chem 277: 267-271.
57. Sanada K, Harada Y, Sakai M, Todo T, Fukada Y, (2004). Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein kinase. Genes Cells 9: 697-708.
58. Shaw IR, Lavigne G, Mayer P, Choinière M, (2005). Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 28: 677-682.
59. Sládek M, Sumová A, Kováciková Z, Bendová Z, Laurinová K, Illnerová H, (2004). Insight into molecular core clock mechanism of embryonic and early postnatal rat suprachiasmatic nucleus. Proc Natl Acad Sci U S A 101: 6231-6236.
60. Tierno A, Fiore P, Gannon RL, (2002). Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms. Brain Res 937: 66-73.
61. Trávníčková Z, Sumová A, Peters R, Schwartz WJ, Illnerová H, (1996). Photoperiod-dependent correlation between light-induced SCN c-fos expression and resetting of circadian phase. Am J Physiol 271: R825-R831.
62. Vansteensel MJ, Deboer T, Dahan A, Meijer JH, (2003). Differential responses of circadian activity onset and offset following GABA-ergic and opioid receptor activation. J Biol Rhythms 18: 297-306.
63. Vansteensel MJ, Magnone MC, van Oosterhout F, Baeriswyl S, Albrecht U, Albus H, et al. (2005). The opioid fentanyl affects light input, electrical activity and Per gene expression in the hamster suprachiasmatic nuclei. Eur J Neurosci 21: 2958-2966.
64. Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY, (2011). Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the Guinea pig. J Pharmacol Exp Ther 339: 438-450.
65. Yoshida M, Ohdo S, Takane H, Tomiyoshi Y, Matsuo A, Yukawa E, et al. (2003). Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice. J Pharmacol Exp Ther 305: 1200-1205.
66. Zylka MJ, Shearman LP, Weaver DR, Reppert SM, (1998). Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20: 1103-1110.